salvin has been researched along with tamoxifen in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Dickmann, LJ; Lin, YS; VandenBrink, BM | 1 |
Han, NN; Huang, Q; Liu, KJ; Zhou, Q | 1 |
2 other study(ies) available for salvin and tamoxifen
Article | Year |
---|---|
In vitro hepatotoxicity and cytochrome P450 induction and inhibition characteristics of carnosic acid, a dietary supplement with antiadipogenic properties.
Topics: Abietanes; Adenosine Triphosphate; Adipogenesis; Cells, Cultured; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Dietary Supplements; Dose-Response Relationship, Drug; Drug Interactions; Hepatocytes; Humans; Microsomes, Liver; Plant Extracts; Rifampin; Weight Loss | 2012 |
Carnosic acid cooperates with tamoxifen to induce apoptosis associated with Caspase-3 activation in breast cancer cells in vitro and in vivo.
Topics: Abietanes; Animals; Apoptosis; Breast Neoplasms; Caspase 3; Cell Line, Tumor; Cell Survival; Drug Therapy, Combination; Enzyme Activation; Female; Gene Expression Regulation, Neoplastic; Humans; Mammary Neoplasms, Experimental; Mice, Nude; Tamoxifen | 2017 |